$169 Million is the total value of New Leaf Venture Partners, L.L.C.'s 19 reported holdings in Q3 2022. The portfolio turnover from Q2 2022 to Q3 2022 was 9.5% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ARVN | ARVINAS INC | $57,371,000 | +5.7% | 1,289,521 | 0.0% | 34.04% | -3.2% | |
| RALLYBIO CORPORATION | $33,304,000 | +91.7% | 2,301,603 | 0.0% | 19.76% | +75.5% | ||
| DCPH | DECIPHERA PHARMACEUTICALS INC | $22,377,000 | +40.7% | 1,209,571 | 0.0% | 13.28% | +28.9% | |
| EWTX | EDGEWISE THERAPEUTICS INC | $15,288,000 | +23.6% | 1,553,661 | 0.0% | 9.07% | +13.2% | |
| DICE THERAPEUTICS INC | $11,290,000 | +30.7% | 556,693 | 0.0% | 6.70% | +19.7% | ||
| COGT | COGENT BIOSCIENCES INC. | $7,483,000 | +65.4% | 501,530 | 0.0% | 4.44% | +51.5% | |
| ALEC | ALECTOR INC | $3,212,000 | -6.9% | 339,569 | 0.0% | 1.91% | -14.7% | |
| PASG | PASSAGE BIO | $3,122,000 | -47.0% | 2,497,922 | 0.0% | 1.85% | -51.5% | |
| AMYT | AMRYT PHARMA PLCsponsored ads | $3,112,000 | -1.0% | 449,737 | 0.0% | 1.85% | -9.4% | |
| HARP | HARPOON THERAPEUTICS INC | $3,062,000 | -49.2% | 3,156,699 | 0.0% | 1.82% | -53.5% | |
| CRNX | CRINETICS PHARMACEUTICALS INC | $2,769,000 | +5.3% | 141,000 | 0.0% | 1.64% | -3.6% | |
| CMRX | CHIMERIX INC | $2,363,000 | -7.2% | 1,224,600 | 0.0% | 1.40% | -15.0% | |
| RENOVACOR CORPORATION | $1,690,000 | +24.3% | 670,689 | 0.0% | 1.00% | +13.8% | ||
| ARAV | ARAVIVE INC | $773,000 | -17.3% | 946,423 | 0.0% | 0.46% | -24.3% | |
| XFOR | X4 PHARMACEUTICALS INC | $573,000 | +77.4% | 335,000 | 0.0% | 0.34% | +62.7% | |
| PDSB | PDS BIOTECHNOLOGY CORP | $348,000 | -18.7% | 117,242 | 0.0% | 0.21% | -25.6% | |
| AVRO | AVROBIO INC | $203,000 | -30.0% | 315,550 | 0.0% | 0.12% | -36.2% | |
| ITRM | Sell | ITERUM THERAPEUTICS PLC | $157,000 | -46.2% | 97,084 | -93.3% | 0.09% | -50.8% |
| ADXN | ADDEX THERAPEUTICS LTDsponsored ads | $40,000 | -31.0% | 50,000 | 0.0% | 0.02% | -36.8% | |
| APTX | Exit | APTINYX INC | $0 | – | -3,290,079 | -100.0% | -1.19% | – |
| SRRA | Exit | SIERRA ONCOLOGY INC | $0 | – | -219,251 | -100.0% | -7.81% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-11-10
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| DECIPHERA THERAPEUTICS INC | 25 | Q3 2023 | 44.4% |
| CHIMERIX INC | 25 | Q1 2023 | 20.9% |
| SIERRA ONCOLOGY INC | 22 | Q2 2022 | 14.9% |
| ARVINAS INC | 21 | Q3 2023 | 44.8% |
| CRINETICS PHARMACEUTICALS INC | 21 | Q3 2023 | 11.4% |
| OBSEVA SA | 20 | Q4 2021 | 8.5% |
| AVROBIO INC | 20 | Q1 2023 | 1.7% |
| HARPOON THERAPEUTICS INC | 19 | Q3 2023 | 20.0% |
| ALECTOR INC | 19 | Q3 2023 | 4.6% |
| ITERUM THERAPEUTICS PLC | 18 | Q3 2022 | 3.8% |
View New Leaf Venture Partners, L.L.C.'s complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-10 |
| 13F-HR | 2023-05-11 |
| 13F-HR | 2023-02-06 |
| 13F-HR | 2022-11-10 |
| 13F-HR | 2022-08-09 |
| 13F-HR | 2022-05-06 |
| 13F-HR | 2022-02-11 |
| 13F-HR | 2021-11-12 |
View New Leaf Venture Partners, L.L.C.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.